Activation of FXR Suppresses Esophageal Squamous Cell Carcinoma Through Antagonizing ERK1/2 Signaling Pathway
Qingqing Feng(Chinese Academy of Sciences), Yan‐Dong Wang(Beijing University of Chemical Technology)
Cited by 15
Related Papers
β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
|Frontiers in Pharmacology|2015|314
The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway
|Oncotarget|2015|55
Farnesoid X Receptor Antagonizes JNK Signaling Pathway in Liver Carcinogenesis by Activating SOD3
|Molecular Endocrinology|2014|45